(Q54472409)

30 May 2018

title

Hexamethylmelamine--a new drug with activity in solid tumors. (English)

1 reference

30 May 2018

author name string

Blum RH

series ordinal

1 reference

30 May 2018

Livingston RB

series ordinal

1 reference

30 May 2018

Carter SK

series ordinal

1 reference

30 May 2018

publication date

1 March 1973

1 reference

30 May 2018

European Journal of Cancer

published in

1 reference

30 May 2018

volume

1 reference

30 May 2018

issue

1 reference

30 May 2018

page(s)

195-202

1 reference

30 May 2018

Insect chemosterilants. V. Derivatives of melamine.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2964%2873%2980019-2

Plasma levels and urinary excretion of hexamethylmelamine following oral administration to human subjects with cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2964%2873%2980019-2

The clinical pharmacology of hexamethylmelamine: Phase I study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2964%2873%2980019-2

Phase II study of hexamethylmelamine (NSC 13875)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2964%2873%2980019-2

Prolonged low-dosage administration of hexamethylmelamine (NC 13875)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2964%2873%2980019-2

Hexamethylmelamine (NSC-13875) in the treatment of primary cancer of the lung with metastasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2964%2873%2980019-2

Alkylating agents in bronchogenic carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2964%2873%2980019-2

Lung cancer: perspectives and prospects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2964%2873%2980019-2

10.1016/S0014-2964(73)80019-2

7 January 2021

Identifiers

DOI

1 reference

30 May 2018

1 reference

30 May 2018